Article

The clinical value of circulating cell free DNA in multiple myeloma

2022-05-04

Abstract excerpt

<h4>Purpose: </h4> To evaluate the feasibility of the detection of circulating cell free DNA (cfDNA) and the prognostic value of cfDNA in patients with multiple myeloma (MM).Experimental design: All samples were screened hematopoietic malignancy associated genetic mutations from cfDNA and bone marrow (BM), using the Next-generation sequencing (NGS). The mutated genetic, checked in both cfDNA and BM, were monitered...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fd124d2b-3609-58f4-9515-dda1eaf1064b
DOI: 10.21203/rs.3.rs-1604204/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The clinical value of circulating cell free DNA in multiple myelomaDOI 10.21203/rs.3.rs-1604204/v1Read

Analysis of Circulating Tumor DNA.Semantic proximity Read

Monitoring multiple myeloma by quantification of recurrent mutations in serum.Semantic proximity Read

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.Semantic proximity Read

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.Semantic proximity Read

High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosisSemantic proximity Read

Tracking myeloma tumor DNA in peripheral blood.Semantic proximity Read

Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor DiseasesSemantic proximity Read

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple MyelomaSemantic proximity Read

Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.Semantic proximity Read

Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.Semantic proximity Read

Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myelomaSemantic proximity Read

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsSemantic proximity Read